COM:PRECISIONBIOSCIENCES
Precision BioSciences, Inc.
- Stock
Last Close
6.50
22/11 21:00
Market Cap
55.69M
Beta: -
Volume Today
105.61K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|
net income | -21.10M - | -46.04M 118.16% | -92.88M 101.74% | -109.01M 17.37% | -30.60M 71.93% | -111.64M 264.80% | -61.32M 45.07% | |
depreciation and amortization | 1.44M - | 2.35M 64.04% | 5.32M 125.87% | 9.81M 84.56% | 10.20M 3.91% | 9.00M 11.70% | 8.26M 8.32% | |
deferred income tax | 22K - | -6.14M - | -1.33M - | |||||
stock based compensation | 419K - | 2.45M 485.44% | 8.94M 264.45% | 13.79M 54.21% | 16.51M 19.79% | 19.20M 16.25% | 14.04M 26.86% | |
change in working capital | -5.09M - | -10.51M 106.22% | -2.36M 77.57% | -2.01M 14.55% | 19.58M 1,072.39% | 24.11M 23.11% | 1.33M 94.50% | |
accounts receivables | -523K - | -441K 15.68% | -9.04M 1,948.75% | 9.51M 205.28% | -232K 102.44% | -181K 21.98% | ||
inventory | -5.95M - | 5.28M 188.85% | 8.01M 51.68% | 4.30M 46.27% | ||||
accounts payables | 864K - | -673K 177.89% | 667K 199.11% | -1.46M 318.14% | 867K 159.59% | 153K 82.35% | 1.51M 885.62% | |
other working capital | -5.96M - | -3.37M 43.53% | -7.87M 133.76% | 463K 105.89% | 4.90M 958.32% | 24.19M 393.65% | -1.33M 105.49% | |
other non cash items | 174K - | 14K 91.95% | 9.94M 70,900% | 35K 99.65% | -20.40M 58,394.29% | 13.57M 166.52% | -46.42M 441.98% | |
net cash provided by operating activities | -24.17M - | -51.72M 114.01% | -71.02M 37.30% | -87.39M 23.05% | -10.85M 87.58% | -45.75M 321.57% | -84.11M 83.84% | |
investments in property plant and equipment | -5.57M - | -15.68M 181.73% | -24.67M 57.33% | -5.03M 79.60% | -5.80M 15.34% | -3.32M 42.81% | -1.96M 41.04% | |
acquisitions net | ||||||||
purchases of investments | ||||||||
sales maturities of investments | ||||||||
other investing activites | 50K - | 15K 70% | 7.79M - | |||||
net cash used for investing activites | -5.51M - | -15.66M 184.01% | -24.67M 57.48% | -5.03M 79.60% | -5.80M 15.34% | -3.32M 42.81% | 5.83M 275.63% | |
debt repayment | -39.55M - | -2.50M - | -19.80M 692.20% | |||||
common stock issued | 135.19M - | 1.33M 99.02% | 60.48M 4,450.56% | 74.34M 22.93% | 4.99M 93.29% | |||
common stock repurchased | -952K - | |||||||
dividends paid | ||||||||
other financing activites | 15K - | 107.78M 718,413.33% | 77.74M 27.87% | 12.54M - | 40.45M 222.43% | 401K 99.01% | ||
net cash used provided by financing activities | -937K - | 107.78M 11,602.35% | 173.37M 60.86% | 1.33M 99.23% | 70.52M 5,206.32% | 94.98M 34.69% | 5.39M 94.33% | |
effect of forex changes on cash | ||||||||
net change in cash | -30.62M - | 40.39M 231.91% | 77.69M 92.35% | -91.09M 217.24% | 53.87M 159.14% | 45.91M 14.76% | -72.90M 258.77% | |
cash at beginning of period | 93.42M - | 62.80M 32.78% | 103.19M 64.31% | 180.89M 75.29% | 89.80M 50.36% | 143.66M 59.98% | 189.58M 31.96% | |
cash at end of period | 62.80M - | 103.19M 64.31% | 180.89M 75.29% | 89.80M 50.36% | 143.66M 59.98% | 189.58M 31.96% | 116.68M 38.45% | |
operating cash flow | -24.17M - | -51.72M 114.01% | -71.02M 37.30% | -87.39M 23.05% | -10.85M 87.58% | -45.75M 321.57% | -84.11M 83.84% | |
capital expenditure | -5.57M - | -15.68M 181.73% | -24.67M 57.33% | -5.03M 79.60% | -5.80M 15.34% | -3.32M 42.81% | -1.96M 41.04% | |
free cash flow | -29.73M - | -67.40M 126.68% | -95.68M 41.96% | -92.42M 3.41% | -16.66M 81.98% | -49.07M 194.62% | -86.07M 75.40% |
All numbers in (except ratios and percentages)